Combination spinal analgesic chemotherapy: a systematic review.
Walker
Suellen M
SM
Department of Anesthesia and Pain Management, Royal North Shore Hospital and University of Sydney, Sydney, Australia.
Goudas
Leonidas C
LC
Cousins
Michael J
MJ
Carr
Daniel B
DB
D000316:Adrenergic alpha-Agonists / Q000627:therapeutic use; D000701:Analgesics, Opioid / Q000008:administration & dosage / Q000627:therapeutic use*; D000779:Anesthetics, Local / Q000627:therapeutic use; D000970:Antineoplastic Agents / Q000008:administration & dosage / Q000627:therapeutic use*; D002800:Cholinesterase Inhibitors / Q000627:therapeutic use; D003000:Clonidine / Q000627:therapeutic use; D018757:GABA Modulators / Q000627:therapeutic use; D006801:Humans; D007278:Injections, Spinal; D008874:Midazolam / Q000627:therapeutic use; D009369:Neoplasms / Q000150:complications / Q000188:drug therapy*; D009388:Neostigmine / Q000627:therapeutic use; D010146:Pain / Q000188:drug therapy* / Q000209:etiology; D016032:Randomized Controlled Trials as Topic; D016194:Receptors, N-Methyl-D-Aspartate / Q000037:antagonists & inhibitors
D000316:Adrenergic alpha-Agonists; D000701:Analgesics, Opioid; D000779:Anesthetics, Local; D000970:Antineoplastic Agents; D002800:Cholinesterase Inhibitors; D018757:GABA Modulators; D016194:Receptors, N-Methyl-D-Aspartate; D009388:Neostigmine; D003000:Clonidine; D008874:Midazolam